Fink Jeffrey Arvin
SEC insider (Form 3/4/5 filer). CIK 0001595930. Director at Lipocine Inc. (LPCN). 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 4, 2025. Located in SALT LAKE CITY, UT.
Companies Fink Jeffrey Arvin has filed insider reports for
- Lipocine Inc. (LPCN): Director
Fink Jeffrey Arvin
CIK: 0001595930
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LPCN
Lipocine Inc.
Director